U.S. Markets closed

iShares Trust - iShares Nasdaq Biotechnology ETF (IBB)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
304.06-0.75 (-0.25%)
At close: 4:00PM EDT
People also watch
XBIXLVXLEXLFIWM
Full screen
Previous Close304.81
Open303.99
Bid303.51 x 100
Ask304.06 x 100
Day's Range302.68 - 306.33
52 Week Range246.71 - 329.90
Volume937,119
Avg. Volume1,178,389
Net Assets9.63B
NAV318.95
PE Ratio (TTM)10.57
Yield0.20%
YTD Return20.43%
Beta (3y)1.35
Expense Ratio (net)0.47%
Inception Date2001-02-05
Trade prices are not sourced from all markets
  • Market Realist16 hours ago

    How Ramsay Health Care Became a Cost Leader

    Ramsay Health Care is a market leader in private healthcare in Australia, treating almost 3 million patients each year.

  • Amid corporate career, Merck CEO exonerated man on death row
    CNBC5 days ago

    Amid corporate career, Merck CEO exonerated man on death row

    Frazier said the experience showed him "why there can be no fair and consistent application of the death penalty under the current system."

  • Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Quiet Bull
    InvestorPlace9 days ago

    Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Quiet Bull

    Shares of biotech giant Amgen, Inc. (NASDAQ:AMGN), while higher by roughly 19% for the year, also remains a pain trade for momentum-chasing traders as well as longer-term investors. The broader large-cap biotech space as represented by the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) is also higher by around 18% for the year, which is to say that AMGN stock in terms of performance is trading just about in line with its peers, on average. All else being equal, this would thus also mean that AMGN stock stands a good chance of continuing to trade with this correlation to the IBB ETF.